- Home
- GEVO vs PRQR Comparison
GEVO vs PRQR Comparison
Compare GEVO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- PRQR
- Stock Information
- Founded
- GEVO 2005
- PRQR 2012
- Country
- GEVO United States
- PRQR Netherlands
- Employees
- GEVO N/A
- PRQR N/A
- Industry
- GEVO Major Chemicals
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- PRQR Health Care
- Exchange
- GEVO Nasdaq
- PRQR Nasdaq
- Market Cap
- GEVO 285.1M
- PRQR 309.5M
- IPO Year
- GEVO 2011
- PRQR 2014
- Fundamental
- Price
- GEVO $1.14
- PRQR $1.55
- Analyst Decision
- GEVO Buy
- PRQR Strong Buy
- Analyst Count
- GEVO 2
- PRQR 6
- Target Price
- GEVO $7.58
- PRQR $9.00
- AVG Volume (30 Days)
- GEVO 2.4M
- PRQR 678.2K
- Earning Date
- GEVO 05-13-2025
- PRQR 05-08-2025
- Dividend Yield
- GEVO N/A
- PRQR N/A
- EPS Growth
- GEVO N/A
- PRQR N/A
- EPS
- GEVO N/A
- PRQR N/A
- Revenue
- GEVO $16,915,000.00
- PRQR $21,212,711.00
- Revenue This Year
- GEVO $617.82
- PRQR $6.44
- Revenue Next Year
- GEVO $84.22
- PRQR N/A
- P/E Ratio
- GEVO N/A
- PRQR N/A
- Revenue Growth
- GEVO N/A
- PRQR 85.91
- 52 Week Low
- GEVO $0.48
- PRQR $1.07
- 52 Week High
- GEVO $3.39
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- GEVO 49.70
- PRQR 50.51
- Support Level
- GEVO $1.00
- PRQR $1.50
- Resistance Level
- GEVO $1.14
- PRQR $2.02
- Average True Range (ATR)
- GEVO 0.08
- PRQR 0.17
- MACD
- GEVO 0.00
- PRQR 0.03
- Stochastic Oscillator
- GEVO 60.87
- PRQR 48.04
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.